Benitec Biopharma Inc.
BNTC· Nasdaq
BNTCBenitec Biopharma Inc.
Filed May 16, 2022 · 10-Q · 46 days after period end · 0001193125-22-150924
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $48.00K | $1.00K | $28.00K |
| Net Income | -$3.28M | -$3.91M | -$2.10M |
| EPS Diluted | -$0.40 | -$0.82 | -$1.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Benitec Biopharma Inc. · CIK 1808898 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 16, 2022 · 46 d after period end
